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Red wine polyphenols modulate fecal microbiota
and reduce markers of the metabolic syndrome in
obese patients
Moreno-Indias Isabel,†a,b Sánchez-Alcoholado Lidia,†a Pérez-Martínez Pablo,b,c
Andrés-Lacueva Cristina,d,e Cardona Fernando,*a,b Tinahones Francisco*a,b and
Queipo-Ortuño María Isabela,b
This study evaluated the possible prebiotic eﬀect of a moderate intake of red wine polyphenols on the
modulation of the gut microbiota composition and the improvement in the risk factors for the metabolic
syndrome in obese patients. Ten metabolic syndrome patients and ten healthy subjects were included in a
randomized, crossover, controlled intervention study. After a washout period, the subjects consumed red
wine and de-alcoholized red wine over a 30 day period for each. The dominant bacterial composition did
not diﬀer signiﬁcantly between the study groups after the two red wine intake periods. In the metabolic
syndrome patients, red wine polyphenols signiﬁcantly increased the number of fecal biﬁdobacteria and
Lactobacillus (intestinal barrier protectors) and butyrate-producing bacteria (Faecalibacterium prausnitzii
and Roseburia) at the expense of less desirable groups of bacteria such as LPS producers (Escherichia coli
and Enterobacter cloacae). The changes in gut microbiota in these patients could be responsible for the
improvement in the metabolic syndrome markers. Modulation of the gut microbiota by using red wine
could be an eﬀective strategy for managing metabolic diseases associated with obesity.
Introduction
The metabolic syndrome (MetS) is a cluster of medical con-
ditions, including obesity and insulin resistance, that increase
the risk of developing type 2 diabetes and cardiovascular dis-
eases, which have become an important epidemic worldwide.1
Recent studies have demonstrated that obesity and the MetS
may be associated with substantial changes in the compo-
sition and metabolic function of the gut microbiota.2 Several
years ago, Vijay-Kumar et al.,3 using transgenic mice, provided
evidence for the direct relationship between the development
of the MetS, a malfunction of the innate immune system, and
changes in the composition of the gut microbiota.
The beneficial eﬀects of prebiotic food products on energy
homoeostasis, satiety regulation, body weight gain and
changes in the composition of the gut microbiota have
recently been analyzed in studies using both animal and
human models.4 Together with data from obese animals and
patients, these studies support the hypothesis that the gut
microbiota composition (especially the number of bifido-
bacteria) may contribute to the modulation of metabolic pro-
cesses associated with the MetS, specifically obesity and type 2
diabetes.5,6
Several intervention studies in humans and animals have
provided further evidence for the protective eﬀects of poly-
phenols in the direction of modulation of vascular and platelet
function, blood pressure, and an improved plasma lipid
profile.7–9 Plant polyphenols, which are organic compounds
found in numerous plant species and their fruits, are being
actively studied as potential treatments for components of the
MetS.10–12 The use of red wine polyphenols may be a potential
mechanism for the prevention of cardiovascular and metabolic
alterations associated with obesity. Agouni et al. have provided
strong evidence for an improvement in obesity-associated
alterations, including glucose and lipid metabolism, as well as
endothelial and cardiac functions due to the beneficial eﬀects
of red wine polyphenols on both vascular and cardiac func-
tions in a Zucker fatty rat model.13†These authors contributed equally to this work.
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The phenolic components in wine also have an eﬀect on
the microbiota. Queipo-Ortuño et al.14 have recently shown
that red wine consumption can significantly modulate the
growth of selected gut microbiota in healthy humans. The con-
sumption of red wine polyphenols significantly increased the
number of Enterococcus, Prevotella, Bacteroides, Bifidobacterium,
Bacteroides uniformis, Eggerthella lenta, and the Blautia coccoides–
Eubacterium rectale group, while the quantity of Lactobacillus
spp. was unaltered. Resveratrol has been identified as
being responsible for changes in the intestinal microbiota in
rats, with an increase in Bifidobacterium and Lactobacillus
levels.15 Anthocyanins have in vitro bacteriostatic activity
against Staphylococcus spp., Salmonella spp., Helicobacter
pylori, and Bacillus cereus, among others.16,17 Catechins and
epicatechins aﬀect the growth of selected microflora, resulting
in an increase in the growth of the Blautia coccoides–Eubacter-
ium rectale group, Bifidobacterium spp. and Escherichia coli, as
well as having an inhibitory eﬀect on the Clostridium histolyti-
cum group.18
A dietary modulation of the gut microbiota and its meta-
bolic output could positively influence host metabolism and
thus constitute a potential coadjuvant approach in the man-
agement of obesity and associated metabolic disorders. Thus,
our aim was to examine the possible prebiotic eﬀect of a mod-
erate intake of red wine polyphenols on the modulation of the
gut microbiota composition and the improvement in the MetS
risk factors in obese patients.
Materials and methods
Study subjects and design
The study involved 20 Caucasian adult men aged 48 ± 2 years
(range 45–50 years). Ten obese participants met the criteria for
the MetS and 10 were healthy subjects (control group). The
MetS patients were recruited if they fulfilled at least three of
the updated criteria for the diagnosis of the MetS according to
the National Cholesterol Education Program’s Adult Treatment
Panel III (ATP III): waist circumference > 102 cm; HDL
cholesterol < 40 mg dL−1 in men; serum triglycerides ≥
150 mg dL−1; fasting blood glucose 110–126 mg dL−1 and
blood pressure ≥ 130/85 mmHg.
Exclusion criteria were established for type 2 diabetes: body
mass index (BMI) > 40 kg m−2; acute or chronic infection,
inflammatory disease or endocrine disorders; history of
cancer; leukocytosis (>10 × 109 cells per L); anti-inflammatory,
corticosteroid, hormone, or antibiotic drug treatment; a
history of alcohol abuse or drug dependence; and a restrictive
diet or a weight change ≥5 kg during the 3 months prior to the
study. None of the 20 volunteers received antibiotic therapy,
prebiotics, probiotics, synbiotics, vitamin supplements or any
other medical treatment influencing intestinal microbiota
during the 3 months before the start of the study or during the
study. A randomized, crossover controlled intervention study
was performed. The study was divided into 4 periods: an
initial washout period of two weeks (baseline) during which
the participants did not consume any red wine, followed by
two intervention periods of 30 days each during which partici-
pants drank only red wine (272 mL per day) or de-alcoholized
red wine (272 mL per day) separated by a washout period of 15
days. Each participant provided 3 diﬀerent fecal samples: a
baseline sample after the washout period and a sample at the
end of each 30 day period. Fasting blood samples and 24 h
urine were also collected at baseline and after each intake
period. The participants did not smoke or drink other alco-
holic beverages and they were only advised to follow the same
qualitative dietary recommendations according to the Ameri-
can Heart Association dietary guidelines,19 in the absence of
any low-in-polyphenols washout diet to mimic their normal
free-living conditions as much as possible. Participants were
also asked to maintain the same level of physical activity
throughout the study. At baseline and after each intervention
period, a medical examination and structured nutrient intake
and physical activity questionnaires were completed. This
information was converted into dietary data using the Pro-
fessional Diet Balancer software (Cardinal Health Systems Inc.,
Edina, MN). The Ethics Committee of the Virgen de la Victoria
Hospital approved the clinical protocol. All the participants
gave written informed consent.
Anthropometric measures
Body weight, height, waist and hip circumference were
measured according to standardized procedures.20
Laboratory measurements
Blood samples were collected after an overnight fast. The
serum was separated into aliquots and immediately frozen at
−80 °C. Serum biochemical parameters were measured in
duplicate. Serum albumin, glucose, cholesterol, HDL chole-
sterol, triglycerides (Randox Laboratories Ltd, Antrim, UK),
bilirubin (Dimension Vista System, Siemens, Tarrytown, NY),
uric acid, C-reactive protein (Dimension autoanalyzer from
Dade Behring Inc., Deerfield, IL, USA), gamma-glutamyl trans-
peptidase, glutamate-oxaloacetate transaminase, and glutamic
pyruvic transaminase (Wako Bioproducts, Richmond, VA, USA)
were all measured using standard enzymatic methods. Low-
density lipoprotein cholesterol was calculated using the Friede-
wald formula. The insulin was analyzed using an immuno-
radiometric assay (BioSource International, Camarillo, CA, USA),
showing a 0.3% cross-reaction with proinsulin. The intra- and
inter-assay CV were 1.9% and 6.3%, respectively.
Resveratrol and dihydroresveratrol metabolites were ana-
lyzed in 24 h urine samples as biomarkers of red wine intake,
by using the technique described by Urpi-Sarda et al.21–23 The
resveratrol metabolites were quantified by using the commer-
cial and available standards. Dihydroresveratrol was provided
by Biopharmalab SL and the concentrations of dihydroresvera-
trol metabolites were quantified by using a dihydroresveratrol
calibration curve.24 Similarly, ethyl glucuronide was measured
in 24 h urine samples by liquid chromatography (LC Agilent
series 1200 coupled with a hybrid quadrupole time-of-flight
QSTAR Elite; Applied Biosystems/MDS Sciex).
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Limulus amebocyte lysate assays
Serum concentrations of LPS were measured by endotoxin
assay, based on a limulus amebocyte extract with a chromo-
genic limulus amebocyte lysate (LAL) assay (QCL-1000; Lonza
Group Ltd). Samples were diluted in pyrogen-free water and
heated to 70 °C for 10 min to inactivate endotoxin neutralizing
agents that inhibit the activity of endotoxin in the LAL assay.
The pyrosperse reagent (Lonza Group Ltd), which is a metallo-
modified polyanionic dispersant, was added at a ratio of
1 : 200 (vol : vol) to test samples before LAL testing to minimize
interference in the reaction. All samples were tested in dupli-
cate, and results were accepted when the intra-assay CV was
10%. The endotoxin content was expressed as endotoxin units
(EU) per milliliter. Exhaustive care was taken to avoid environ-
mental endotoxin contamination, and all of the material used
for both sample preparation and the test was pyrogen-free.
DNA extraction from fecal samples
Fecal samples were collected and immediately stored at −80 °C
until analysis. DNA extraction from 200 mg of stools was per-
formed using the QIAamp DNA stool Mini kit (Qiagen, Hilden,
Germany) following the manufacturer’s instructions. The DNA
concentration was determined by absorbance at 260 nm, and
the purity was estimated by determining the A260/A280 ratio
with a Nanodrop spectrophotometer (Nanodrop Technologies,
Wilmington, DE, USA).
Analysis of fecal microbiota by polymerase chain reaction-
denaturing gradient gel electrophoresis (PCR-DGGE)
Fecal samples from each subject were examined by determin-
ing PCR-DGGE profiles. The V2–V3 region of the 16S rRNA
genes (positions 339–539 in the Escherichia coli gene) of bac-
teria in the fecal samples was amplified with the primers
HDA1-GC (5′-CGC CCG CCG CGC GCG GCG GGC GGG GCG
GGG GCA CGG GGG GCC TAC GGG AGG CAG CAG T-3′ (the
GC clamp is in boldface) and HDA2 (5′-GTA TTA CCG CGG
CTG CTG GCA C-3′). Aliquots (2 μL) of DNA were amplified by
RT-PCR (20 μL final volume) in a 7500 Fast RT-PCR systems
instrument using Fast SYBR Green Master Mix and 200 nM of
each of the universal primers HDA1-GC/HDA2 with the follow-
ing amplification program: initial denaturation at 95° for 20 s,
amplification using 45 cycles including denaturation at 95 °C
for 3 s, annealing at 55 °C for 30 s and extension at 72 °C for
1 min.
After RT-PCR, 15 μL of products were mixed with a 6 μL
loading dye before loading. Electrophoresis was performed
with a DCode™ Universal Mutation Detection System instru-
ment (Bio-Rad). 6% Polyacrylamide gels were prepared and
electrophoresed with 1× TAE buﬀer prepared from 50× TAE
buﬀer (2 M Tris base, 1 M glacial acetic acid, 50 mM EDTA).
The denaturing gradient was formed by using two 6% acryl-
amide (acrylamide/bisacrylamide ratio, 37.5 : 1) stock solutions
(Bio-Rad). The gels contained a 20–80% gradient of urea and
formamide, increasing in the direction of electrophoresis.
Electrophoretic runs were performed in a Tris-acetate–EDTA
buﬀer (TAE 1×) (40 mmol L−1 Tris, 20 mmol L−1 acetic acid,
and 1 mmol L−1 EDTA, pH 7.4) at 130 V and 60 °C for 4.5 h.
Electrophoresis was stopped when a xylene cyanol dye marker
reached the bottom of the gel. Gels were stained with ethidium
bromide (0.5 mg L−1) for 5 min, rinsed with deionized water,
viewed by UV transillumination and photographed with Gel-
capture image acquisition software (DNR Bio-Imaging Systems
Ltd). Similarities between banding patterns in the DGGE
profile were calculated based on the presence and absence of
bands and expressed as a similarity coeﬃcient (Cs). Gels were
analyzed using BioNumerics software (Applied Maths, Sint-
Martens-Latem, Belgium). Normalized banding patterns were
used for cluster analysis. The Dice similarity coeﬃcient was
used to calculate pairwise comparisons of the DGGE finger-
print profiles obtained. A Cs value of 100% indicates that
DGGE profiles are identical while completely diﬀerent profiles
result in a Cs value of 0%. The UPGMA (unweighted pair
group method with arithmetic mean) algorithm was used for
the construction of dendrograms.
Sequencing of bands from DGGE gels
Bands were excised from DGGE gels with a sterile razor, placed
in 40 μL sterile water and incubated at 4 °C for diﬀusion of
DNA into the water. DNA was used in a second PCR with
HDA1/2 primers without a GC clamp (initial denaturation 95°
for 20 s, followed by 45 cycles including denaturation at 95 °C
for 3 s, annealing at 55 °C for 15 s and extension at 72 °C for
10 s). PCR products were diluted until 20 ng μL−1, purified
with ExoSAP-IT (USB Corporation, Miles Road, Cleveland,
Ohio, USA) and sequenced in an ABI 3130 (Applied Bio-
systems) using the BigDye-Kit-Standard. Nucleotide sequence
data obtained were analyzed using MicroSeqID v2.1.1 software
(Applied Biosystems).
Microbial quantification by real-time quantitative PCR
Specific primers targeting diﬀerent bacterial genera were used
to characterize the fecal microbiota by real-time quantitative
PCR (Table 1).25–38 Briefly, real-time quantitative PCR experi-
ments were performed with a LightCycler 2.0 PCR sequence
detection system using the FastStart DNA Master SYBR Green
kit (Roche Diagnostics, Indianapolis, IN, USA). All PCR tests
were carried out in duplicate with a final volume of 20 μL, con-
taining 1 μL of each fecal DNA preparation and 200 nM of
each primer (Table 1). The thermal cycling conditions used
were as follows: an initial DNA denaturation step at 95 °C for
10 min, followed by 45 cycles of denaturation at 95 °C for 10 s,
primer annealing at the optimal temperature (Table 1) for 20 s,
and extension at 72 °C for 15 s. Finally, melt curve analysis
was performed by slowly cooling the PCRs from 95 to 60 °C
(0.05 °C per cycle) with simultaneous measurement of the
SYBR Green I signal intensity. Melting-point-determination
analysis allowed the confirmation of the specificity of the
amplification products.
The bacterial concentration from each sample was calcu-
lated by comparing the Ct values obtained from the standard
curves with the LightCycler 4.0 software. Standard curves were
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created using serial tenfold dilution of pure cultures of DNA,
corresponding to 101–1010 copies per gram of feces. The
diﬀerent strains used were obtained from the Spanish Collec-
tion of Type Cultures (CECT) (Bacteroides vulgatus NCTC
11154, Fusobacterium varium NCTC 10560, Enterococcus faecalis
CECT 184, Enterobacter cloacae CECT 194, Clostridium perfrin-
gens CECT 376) and the American Collection of Type Cultures
(ACTC) (Bifidobacterium bifidum ATCC 15696, Lactobacillus
casei ATCC 334D-5, Prevotella intermedia ATCC 25611D-5, Clos-
tridium histolyticum, ATCC 19401, Eggerthella lenta, ATCC
25559, Bacteroides uniformis ATCC8492, Ruminococcus produc-
tus, ATCC 27340D-5, Faecalibacterium prausnitzii (ATCC 27768)
and Leibniz-Institut DSMZ (Roseburia intestinalis L1–82). The
data presented are the mean values of duplicate real-time PCR
analyses.
Red wine composition
The red wine and de-alcoholized red wine used in this study
were elaborated with the Merlot grape variety, from the
Penedes appellation. The de-alcoholized red wine had the
same composition and polyphenolic compounds as the red
wine, except for the ethanol.14 The phenolic profile of the red
wine was determined by HPLC with diode-array detection as
described previously39 and the resveratrol and piceid contents
were determined by HPLC with diode-array detection as
described by Romero-Pérez et al.40 The description of the daily
alcohol and polyphenol consumption from the 272 mL of red
wine and de-alcoholized red wine used in this study is shown
in Table 2.
Statistical analysis
Results are expressed as mean values and standard deviations.
The statistical analysis was performed with SPSS 15.0 software
(SPSS Inc., Chicago, IL, USA). The 16S rRNA gene copy values
were converted into logarithmic values before the statistical
analysis. A Wilcoxon signed-rank test with a Bonferroni post
hoc test was used to compare the treatments (changes in bio-
chemical and anthropometric variables and in bacterial
number) in each study group. The Mann–Whitney U test was
used to compare the MetS patients with the healthy subjects at
baseline and after red wine and de-alcoholized red wine intake
periods. One-way analysis of variance (ANOVA) for repeated
Table 1 Primers used for real-time PCR
Target group Oligonucleotide sequence (5′–3′) Reference
Bacteroidetes CATGTGGTTTAATTCGATGAT Guo et al., 2008 25
AGCTGACGACAACCATGCAG
Bacteroides GAGAGGAAGGTCCCCCAC Guo et al., 2008 25
CGCTACTTGGCTGGTTCAG
Lactobacillus GAGGCAGCAGTAGGGAATCTTC Delroisse et al., 2008 26
GGCCAGTTACTACCTCTATCCTTCTTC
Fusobacterium CCCTTCAGTGCCGCAGT Friswell et al., 2010 27
GTCGCAGGATGTCAAGAC
Firmicutes ATGTGGTTTAATTCGAAGCA Guo et al., 2008 25
AGCTGACGACAACCATGCAC
Actinobacteria CGCGGCCTATCAGCTTGTTG Stach et al., 2003 28
CCGTACTCCCCAGGCGGGG
Bifidobacterium CTCCTGGAAACGGGTGG Matsuki et al., 2002 29
GGTGTTCTTCCCGATATCTACA
Prevotella GGTTCTGAGAGGAAGGTCCCC Bekele et al., 2010 30
TCCTGCACGCTACTTGGCTG
Enterococcus CCCTTATTGTTAGTTGCCATCATT Rinttila et al., 2004 31
ACTCGTTCTTCCCATGT
Proteobacteria CATGACGTTACCCGCAGAAGAAG Friswell et al., 2010 27
CTCTACGAGACTCAAGCTTGC
Clostridium GCACAAGCAGTGGAGT Matsuki et al., 2004 29
Cluster IV CTTCCTCCGTTTTGTCAA
Eggerthella lenta TGGCGAACGGGTGAGTAA Lau et al., 2004 32
AGGCCCGGGAA CGTATTCAC
Blautia coccoides–Eubacterium rectale group CGGTACCTGACTAAGAAGC AGTTTCATTCTTGCGAACG Rinttila et al., 2004 31
Clostridium histolyticum group ATGCAAGTCGAGCGA(G/T)G TATGCGGTATTAATCT(C/T)CCTTT Rinttila et al., 2004 31
Bacteroides uniformis TCCGTTTTCCACTTATAAGA Liu et al., 2003 33
GGGTTBCCCCATTCGG
Parabacteroides distasonis TGCCTATCAGAGGGGGATAAC GCAAATATTCCCATGCGGGAT Tong et al., 2011 34
Escherichia coli GACTGCAAAGACGTATGTAGATTCG ATCTATCCCTCTGACATCAACTGC Sharma et al., 1999 35
Enterobacter cloacae CGAGAGCCTGUTGCTG GAT TGGCTGACCCAAT Anbazhagan et al., 2010 36
Faecalibacterium prausnitzii GGAGGAAGAAGGTCTTCGG AATTCCGCCTACCTCTGCACT Payne et al., 2011 37
Roseburia TACTGCATTGGAAACTGTCG CGGCACCGAAGAGCAAT Larsen et al., 2010 38
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measures with the Bonferroni post hoc test was used to
compare changes in the dietary analysis in response to the
intervention treatments in each study group. Student’s t-test
for independent samples was used to analyze changes in
dietary analysis between the MetS patients and the healthy
subjects at baseline and after the two red wine intake periods.
The Spearman correlation coeﬃcient was calculated to esti-
mate the linear correlations between variables. A multivariate
regression analysis was performed to identify individual bac-
teria as independent predictors for blood pressure, plasma
lipid profile and inflammation markers in both study groups
after the polyphenol interventions (red wine and de-alcoho-
lized red wine). Statistical significance was set at a P value
of <0.05.
Results
Anthropometric and biochemical measurements
The biochemical and anthropometric characteristics of the
patients and controls are shown in Table 3. As expected, sub-
jects in the MetS group had a significantly higher weight, waist
and hip circumferences, BMI, DBP, SBP, glucose, GGT, trigly-
cerides, total cholesterol, CRP and LPS and significantly lower
HDL cholesterol than the healthy subjects at baseline. On the
other hand, in the MetS group, after the red wine and de-alco-
holized red wine intake periods, we observed a statistically sig-
nificant decrease in the SBP, DBP, glucose, triglycerides, total
cholesterol, CRP and LPS and a significant increase in the
serum level of HDL cholesterol with respect to baseline. Never-
theless, the healthy subjects exhibited a significant decrease in
the levels of GPT and plasma cholesterol after the red wine
and de-alcoholized red wine intake periods with respect to
baseline. No significant diﬀerences in the anthropometric and
biochemical variables were found when comparing the red
wine and de-alcoholized red wine intake periods within the
MetS patients and the healthy groups. Finally, after the red
wine and de-alcoholized red wine intake periods we only
found significant diﬀerences in weight, waist and hip circum-
ferences, BMI, GGT and triglycerides between the two study
groups (Table 3).
Diet and intervention compliance
The red wine and de-alcoholized red wine were well tolerated
by all the volunteers, who all completed the study, and no
intolerance or adverse events were reported. No significant
diﬀerences in dietary intake data were found during the study
in the MetS patients and healthy subjects or between the two
study groups at the basal level and in the diﬀerent intake
periods (Table 4).
Resveratrol metabolites derived from phase II metabolism
and dihydroresveratrol produced by intestinal microbiota were
significantly increased in urine after both red wine intakes
compared to the basal level.
After red wine and de-alcoholized red wine intake, resvera-
trol metabolites were significantly increased compared to base-
line [4.49 µmol (95% CI: 1.36, 7.63)] and [5.03 µmol (95% CI:
2.25, 7.80)] (P < 0.001) respectively. Total dihydroresveratrol
after de-alcoholized red wine and red wine intake were also sig-
nificantly increased compared with baseline 3.58 µmol (95%
CI: 1.18, 6.17) and 4.57 µmol (95% CI: 0.42, 8.79), respectively
(P < 0.001).
Alcoholic intake was monitored after the two treatments by
urinary ethylglucuronide output. After red wine intake the
urinary ethylglucuronide concentration was significantly
increased compared with baseline [358% (95% CI: 146, 570%)
(P < 0.05)]. Nevertheless, no significant diﬀerences in urinary
Table 2 Daily polyphenol and alcohol consumption from 272 mL of
red wine and 272 mL of de-alcoholized red wine used in this study
De-alcoholized
red wine Red wine P*
Total phenols (meq GA)a 733.02 ± 23.61 797.86 ± 102.63 0.426
Phenolic compounds (mg)b
Flavan-3-ols
Catechin 34.39 ± 3.63 33.60 ± 3.07 0.786
Epicatechin 19.20 ± 2.24 18.46 ± 2.11 0.699
Procyanidin B1 17.50 ± 2.10 17.52 ± 1.52 0.712
Procyanidin B2 12.92 ± 1.44 12.41 ± 0.74 0.502
Procyanidin B3 7.48 ± 0.08 6.85 ± 0.08 0.526
Procyanidin B4 13.19 ± 1.35 13.33 ± 1.54 0.934
Anthocyanins
Delphinidin-3-glucoside 4.00 ± 0.44 4.15 ± 0.24 0.589
Petunidin-3-glucoside 3.27 ± 0.31 3.34 ± 0.29 0.755
Peonidin-3-glucoside 1.82 ± 0.16 1.84 ± 0.17 0.797
Malvidin-3-glucoside 13.56 ± 1.16 13.28 ± 1.21 0.787
Malvidin-(6-acetyl)-
3-glucoside
2.83 ± 0.33 2.98 ± 0.26 0.563
Malvidin-(6-coumaroyl)-
3-glucoside
0.96 ± 0.09 1.13 ± 0.07 0.066
Flavonols
Quercetin-3-glucuronide 3.06 ± 0.39 3.23 ± 0.38 0.770
Quercetin 6.48 ± 0.64 7.25 ± 0.21 0.161
Isorhamnetin 0.80 ± 0.04 0.91 ± 0.07 0.114
Hydroxycinnamic acids
2-S-Glutathionylcaftaric 2.93 ± 0.34 2.80 ± 0.27 0.956
trans-Caftaric 5.23 ± 0.44 5.06 ± 0.39 0.595
trans-Caﬀeic 3.31 ± 0.25 3.13 ± 0.22 0.246
trans-Coutaric 1.53 ± 0.14 1.42 ± 0.12 0.182
Stilbenes
trans-Resveratrol 0.74 ± 0.06 0.79 ± 0.10 0.352
cis-Resveratrol 0.75 ± 0.04 0.76 ± 0.04 0.761
trans-Piceid 2.86 ± 0.26 2.56 ± 0.31 0.160
cis-Piceid 1.93 ± 0.24 2.10 ± 0.09 0.226
Hydroxybenzoic acids
Gallic acid 19.90 ± 1.91 18.63 ± 1.74 0.306
Protocatechuic acid 1.59 ± 0.14 1.42 ± 0.17 0.246
Tyrosols
Tyrosol 13.01 ± 1.06 11.86 ± 1.29 0.298
Alcoholic content (g) <1 30
*Comparison between red wine and de-alcoholized red wine
polyphenols (Student’s t-test for independent samples). a Total
polyphenols: expressed as mean ± SD (n = 2) milliequivalents of gallic
acid (meq GA). bResults are expressed as mean ± SD (n = 2) mg per
dose except for alcoholic content.
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ethylglucuronide concentration were observed between de-
alcoholized red wine and baseline [36% (95% CI: 25, 47%)
(P = 0.638)]. Compliance with the red wine intervention was
ensured by empty bottles returned and analyzing the partici-
pants’ reports.
PCR-DGGE fingerprint analysis and bacterial band
identification in the fecal samples
Variations were found in the presence or absence (qualitative)
and intensity (quantitative) of the bands at baseline with
respect to the red wine period in both the MetS patients and
the healthy subjects in the host-specific fingerprints. DGGE
band profiles showed diﬀerences in band richness between
the two groups. Analyzing the diversity of microbiota, we
found that at baseline there was a significant diﬀerence in the
mean DGGE bands between the MetS patients and the healthy
subjects (11.4 ± 1.3 vs. 15.9 ± 1.4; P < 0.001). However, after the
red wine and de-alcoholized red wine periods the diﬀerences
in band richness between the MetS patients and the healthy
subjects were not significant (17.4 ± 1.8 vs. 17.9 ± 1.6, P =
0.520 and 18.2 ± 1.5 vs. 18.6 ± 1.4, P = 0.545, respectively). On
the other hand, some bands were observed in fingerprints
Table 3 Anthropometric and biochemical variables, during the study, of MetS patients and healthy subjects
MetS patients Healthy subjects
Baseline
(washout period) Red wine period
De-alcoholized
red wine period
Baseline
(washout period) Red wine period
De-alcoholized
red wine period
Weight (kg) 113.30 ± 16.54a,* 110.86 ± 16.13a,§ 110.02 ± 14.86a,¥ 82.38 ± 12.37a 81.88 ± 13.10a 81.68 ± 11.34a
Waist (cm) 116.30 ± 10.90a,* 116.00 ± 9.82a,§ 115.26 ± 10.82a,¥ 96.2 ± 4.70a 95.6 ± 5.75a 95.01 ± 5.32a
Hip (cm) 117.70 ± 8.45a,* 117.0 ± 9.24a,§ 116.80 ± 8.98a,¥ 104.4 ± 7.70a 102.60 ± 6.84a 101.9 ± 6.98a
DBP (mmHg) 94.20 ± 9.83a,* 85.20 ± 9.15b 84.0 ± 8.52b 82.60 ± 8.76a 81.80 ± 8.12a 81.12 ± 7.98a
SBP (mmHg) 134.13 ± 10.52a,* 123.6 ± 9.23b 121.06 ± 8.45b 118.45 ± 9.12a 116.23 ± 9.91a 115.93 ± 8.58a
BMI (kg m−2) 35.24 ± 4.21a,* 34.49 ± 4.17a,§ 34.53 ± 4.23a,¥ 27.52 ± 2.10a 27.34 ± 2.31a 27.27 ± 2.19a
Glucose (mg dL−1) 137.00 ± 16.78a,* 107.30 ± 15.12b 102.8 ± 12.7b 100.6 ± 8.26a 99.60 ± 8.90a 97.2 ± 8.14a
Uric acid (mg dL−1) 5.02 ± 1.26a 5.01 ± 1.03a 4.97 ± 1.15a 5.48 ± 0.99a 5.01 ± 0.53a 5.10 ± 0.67a
GOT (mg dL−1) 21.80 ± 8.16a 20.5 ± 6.45a 18.27 ± 4.67a 22.20 ± 7.19a 18.40 ± 3.25a 17.76 ± 3.84a
GPT (mg dL−1) 47.0 ± 10.83a 42.0 ± 9.30a 43.4 ± 7.40a 46.80 ± 5.28a 41.5 ± 3.95b 39.09 ± 3.39a
GGT (mg dL−1) 43.20 ± 7.29a,* 38.20 ± 7.22a,§ 39.0 ± 7.40a,¥ 30.60 ± 5.81a 27.00 ± 4.26a 26.89 ± 5.01a
Triglycerides (mg dL−1) 365.80 ± 24.18a,* 257.6 ± 22.55b,§ 248.92 ± 26.35b,¥ 125.00 ± 18.09a 111.2 ± 19.33a 119.6 ± 19.62a
Cholesterol (mg dL−1) 289.40 ± 18.03a,* 184.66 ± 13.08b 179.96 ± 17.98b 191.40 ± 10.15a 180.40 ± 9.21b 178.90 ± 8.57b
LDL cholesterol (mg dL−1) 138.60 ± 22.64a 133.80 ± 26.73a 131.6 ± 25.6a 120.60 ± 23.88a 117.60 ± 34.51a 115.0 ± 31.24a
HDL-cholesterol (mg dL−1) 41.60 ± 9.60a,* 51.0 ± 9.84b 52.80 ± 8.84b 66.0 ± 10.8a 57.80 ± 11.20a 58.66 ± 8.96a
CRP (mg L−1) 8.20 ± 2.57a,* 5.37 ± 2.23b 5.01 ± 2.06b 4.46 ± 1.84a 3.80 ± 1.56a 3.59 ± 1.10a
LPS (EU per ml) 0.28 ± 0.05a,* 0.11 ± 0.03b 0.11 ± 0.02b 0.14 ± 0.07a 0.12 ± 0.03a 0.11 ± 0.01a
Values are presented as means ± SD. N = 10 subjects per group. DBP, diastolic blood pressure, SBP, systolic blood pressure; GGT, gamma-
glutamyl transferase; GOT, glutamic oxaloacetic transaminase; GPT, glutamic pyruvic transaminase, CRP, C reactive protein. Values in a row with
diﬀerent superscript letters are significantly diﬀerent P < 0.05. *Diﬀerences between MetS patients and healthy subjects at baseline P < 0.05.
§Diﬀerences between MetS patients and healthy subjects after red wine intake P < 0.05. ¥Diﬀerences between MetS patients and healthy subjects
after de-alcoholized red wine intake P < 0.05.
Table 4 Results of energy and dietary intakes in MetS patients and healthy subjects at baseline and after the red wine and de-alcoholized red wine
intake periods
MetS patients Healthy subjects
Baseline
(washout
period)
De-alcoholized
red wine
intervention
Red wine
intervention P*
Baseline
(washout
period)
De-alcoholized
red wine
intervention
Red wine
intervention P*
Energy (kcal d−1) 2007.7 ± 340.5a 1919.8 ± 376.2a 1915.3 ± 332.0a 0.392 1978.5 ± 368.0a 1930.7 ± 313.1a 1985.3 ± 360.2a 0.772
Total protein (g d−1) 71.2 ± 22.2a 70.8 ± 28.4a 69.5 ± 30.0a 0.126 70.7 ± 27.2a 69.7 ± 20.8a 68.6 ± 28.8a 0.888
Carbohydrates (g d−1) 170.8 ± 66.0a 165.2 ± 64.5a 163.9 ± 57.1a 0.345 167.0 ± 63.2a 165.2 ± 67.7a 166.8 ± 70.1a 0.633
Dietary fiber (g d−1) 17.0 ± 7.1a 17.3 ± 5.6a 16.9 ± 6.5a 0.786 16.7 ± 5.5a 17.1 ± 6.5a 16.9 ± 5.8a 0.176
Sugars (g d−1) 68.5 ± 26.4a 67.5 ± 30.7a 68.1 ± 33.0a 0.567 66.5 ± 30.3a 66.1 ± 34.7a 65.3 ± 37.9a 0.165
Total lipids (g d−1) 81.5 ± 33.6a 80.7 ± 32.1a 79.9 ± 36.2a 0.661 77.8 ± 37.6a 76.7 ± 40.3a 77.6 ± 42.8a 0.942
Total polyphenols (mg d−1) 409.0 ± 97.3a 390.5 ± 89.3a 381.9 ± 92.8a 0.749 391.5 ± 86.9a 393.6 ± 98.6a 387.7 ± 77.4a 0.921
Values are presented as mean ± SD. N = 10 subjects per group. Energy, nutrient and total polyphenol contributions from interventions were
excluded. *Changes in outcome variables in response to the intervention treatment were determined by repeated-measures 1-factor ANOVA.
P < 0.05 (Bonferroni post hoc test). A Student’s t-test for independent samples was used to look for the diﬀerences between groups. Diﬀerent
superscript letters are significantly diﬀerent (P < 0.05).
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from all the periods (in a diﬀerent lane but at the same posi-
tion), indicating that specific species of the predominant
microbiota were common to all groups.
The Dice similarity coeﬃcient was used to calculate the
similarity index of the DGGE band profiles for the two partici-
pant groups after the red wine and de-alcoholized red wine
intake periods. The mean similarity index in the MetS patients
was 29.6 ± 7.13% and 30.1 ± 7.42% respectively and in healthy
subjects it was 27.08 ± 8.07% and 28.1 ± 7.75% respectively,
with no significant diﬀerences between the study groups
during these two intervention periods (P = 0.469 and P =
0.563).
All the bands from all subject profiles at baseline and after
the red wine and de-alcoholized red wine periods in the two
study groups were cloned and sequenced to identify the domi-
nant microbiota and the sequence similarity matches for
bands were analyzed by using MicroSeqID v2.1.1 software. Bac-
terial identification showed that the majority of the bacteria
represented in our fingerprints corresponded to four phyla
(Table 4). Most of the sequences belonged to Firmicutes and
Bacteroidetes, with the rest distributed among Actinobacteria
and Proteobacteria. Nevertheless, we also observed important
diﬀerences between the MetS patients and the healthy subjects
in the frequencies of diﬀerent genera within these phyla at
baseline. In the MetS patients at baseline, we found an
increase in the frequencies of Bacteroides, Clostridium and
Escherichia accompanied by a decrease in the frequencies of
Prevotella and the absence of Lactobacillus and Bifidobacterium
with respect to healthy subjects. Finally, after red wine and de-
alcoholized red wine intake we found no diﬀerences in the fre-
quency of appearance at diﬀerent taxa levels between both the
study groups (Table 5).
Comparative analysis of gut microbiota communities between
the MetS patients and healthy subjects at baseline and after
the red wine and de-alcoholized red wine intake periods
Changes in the bacterial population abundance at the phylum
and genus levels were assessed in the fecal samples of the two
study groups at baseline and after each intervention period
(Table 6). At baseline, a significant increase in the number of
Proteobacteria and Firmicutes was found in the MetS patients
with respect to the healthy subjects, while after the red wine
and de-alcoholized red wine intake periods no significant
diﬀerences at the phylum level were found between the study
groups. Nevertheless, in the MetS subjects we observed a sig-
nificant increase in the number of Fusobacteria and Bactero-
idetes and a significant decrease in Firmicutes after the red wine
and de-alcoholized red wine periods with respect to baseline.
Also, in the healthy group we observed a significant increase
in Bacteroidetes when compared to baseline after both the red
wine and the de-alcoholized red wine intake periods.
Within Firmicutes, in the MetS patients we found a signifi-
cant decrease in the number of the Clostridium and the Clostri-
dium histolyticum group accompanied by a significant increase
in the quantities of the Blautia coccoides–Eubacterium rectale
group, Faecalibacterium prausnitzii, Roseburia and Lactobacillus
after the red wine and de-alcoholized red wine intake periods
compared to baseline. In the healthy group we have only
observed a significant increase in the number of Faecalibacter-
ium prausnitzii and Roseburia through the intervention study.
Moreover, the significant diﬀerences in the bacteria number of
the Blautia coccoides–Eubacterium rectale group, Clostridium,
Clostridium histolyticum group and Lactobacillus observed at
the baseline level between the study groups disappeared after
the two red wine intervention periods.
Table 5 Bacterial identiﬁcation after the sequencing of the bands from the DGGE analysis of fecal samples at baseline and after the red wine and
de-alcoholized red wine intake periods in both study groups
MetS patients Healthy subjects
Bacteria genus
(sequencing results
of the bands)
Baseline
(washout period)a
n = 77
Red wine
perioda
n = 84
De-alcoholized
red wine perioda
n = 86
Baseline
(washout period)a
n = 80
Red wine
perioda
n = 84
De-alcoholized
red wine perioda
n = 86
Sequence
similarity
(%)
Phylum Bacteroidetes
Genus Bacteroides 27 (35.06%) 20 (23.80%) 20 (23.25%) 15 (18.75%) 19 (22.61%) 20 (23.25%) 99.86
Genus Prevotella 9 (11.68%) 19 (22.61%) 20 (23.25%) 21 (26.25%) 19 (22.61%) 19 (22.09%) 99.95
Phylum Firmicutes
Genus Clostridium 24 (31.16%) 14 (16.66%) 14 (16.27%) 17 (21.25%) 14 (16.66%) 13 (15.11%) 99.76
Genus Lactobacillus 0 13 (15.47%) 14 (16.27%) 9 (11.25%) 13 (15.47%) 15 (17.44%) 97.69
Phylum Actinobacteria
Genus Bifidobacterium 0 12 (14.28%) 13 (15.11%) 10 (12.50%) 13 (15.66%) 13 (15.11%) 99.99
Phylum Proteobacteria
Genus Campylobacter 5 (6.49%) 2 (2.38%) 1 (1.16%) 3 (3.75%) 2 (2.38%) 2 (2.32%) 99.70
Genus Acinetobacter 3 (3.89%) 2 (2.38%) 2 (2.32%) 2 (2.50%) 2 (2.38%) 2 (2.32%) 99.68
Genus Escherichia 9 (11.68%) 2 (2.38%) 2 (2.32%) 3 (3.75%) 2 (2.38%) 2 (2.32%) 99.88
a Refers to the frequency (and percent) of each unique bacteria genus in the baseline or red wine or de-alcoholized red wine intake periods. “n”
refers to the number of bands cloned, sequenced and identified in each study group. N = 10 subjects per group.
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Within Bacteroidetes, a significant decrease in the number
of Bacteroides and a significant increase in Prevotella were
observed in the MetS group after red wine and de-alcoholized
red wine intake compared to baseline. Similarly, in the healthy
group, a significant decrease in the number of Bacteroides uni-
formis was found only when compared to baseline after the red
wine and de-alcoholized red wine periods. In addition, at base-
line we found a significantly higher quantity of Bacteroides and
Parabacteroides distasonis and a lower number of Prevotella in
the MetS group with respect to the healthy group. Nevertheless
no diﬀerence was observed after the two red wine intake
periods when compared to the study groups.
Within Actinobacteria significant increases in the number of
Bifidobacterium and Eggerthella lenta were observed in the MetS
patients and healthy subjects after the red wine and de-alcoho-
lized red wine periods with respect to baseline. The significant
diﬀerence found at the basal level in these two genera when
compared to the MetS patients and healthy volunteers was not
seen after the red wine and de-alcoholized red wine periods.
Finally, at baseline, within Proteobacteria we observed a sig-
nificant increase in the number of Escherichia coli and Entero-
bacter cloacae in the MetS group compared to healthy subjects,
but these significant diﬀerences disappeared after the red
wine intake periods. Moreover, in the MetS group, a significant
decrease in the number of Escherichia coli and Enterobacter
cloacae was observed after the red wine and de-alcoholized red
wine intake with respect to the baseline period. No significant
diﬀerences were found in the healthy subjects in the quantity
of Escherichia coli and Enterobacter cloacae when compared to
baseline after the red wine intake periods.
Relationship between gut microbiota composition and blood
pressure, plasma glucose level, plasma lipid profile and
inflammation markers in both study groups
After the polyphenol interventions (red wine and de-alcoholized
red wine), in the MetS patients we found a significant univariate
correlation between changes in the amount of specific bacteria
at diﬀerent taxa levels and plasma triglycerides, cholesterol,
HDL-cholesterol, glucose and CRP (Table 7). In the healthy sub-
jects, however, we only observed significant univariate corre-
lations between changes in the amount of specific bacteria and
HDL-cholesterol, glucose and SBP (Table 8).
In the MetS group, using a multivariate regression analysis
that included all the bacterial groups analyzed, only the
increase in Actinobacteria (P = 0.005, β = 1.11, R2 = 0.99) and
Lactobacillus (P < 0.001, β = 0.224, R2 = 0.99) and the decrease
in Clostridium histolyticum (P = 0.029, β = −0.194, R2 = 0.99)
and Escherichia coli (P = 0.029, β = −0.194, R2 = 0.99) predicted
the triglyceride reduction. Moreover, the increases in the
numbers of Bifidobacterium (P = 0.001, β = 1.004, R2 = 0.99) and
Faecalibacterium prausnitzii (P = 0.001, β = 1.10, R2 = 0.99) were
associated with the reductions in plasma cholesterol and
glucose levels respectively. On the other hand, the decrease in
CRP was predicted by the decrease in Clostridium (P = 0.040,
β = −0.762 R2 = 0.97), and the reduction in plasma LPS levels
was associated with Bifidobacterium growth (P = 0.015,
Table 6 Real-time quantitative PCR of microbiota phyla, genera, groups and species in both study groups. The absence of superscripts § and ¥ in
the table indicate no signiﬁcant diﬀerences
MetS patients Healthy subjects
Baseline
(washout period)
Red wine
period
De-alcoholized
red wine period
Baseline
(washout period)
Red wine
period
De-alcoholized
red wine period
Proteobacteria 8.84 ± 1.78a,* 7.58 ± 1.08a 7.64 ± 0.75a 6.83 ± 1.89a 6.53 ± 2.17a 6.48 ± 2.15a
Escherichia coli 9.29 ± 2.69a,* 7.41 ± 1.35b 7.27 ± 1.99b 7.31 ± 1.41a 7.32 ± 2.97a 7.28 ± 1.78a
Enterobacter cloacae 8.99 ± 1.84a,* 7.01 ± 1.43b 6.89 ± 1.39b 6.89 ± 1.32a 6.78 ± 1.28a 6.63 ± 1.32a
Fusobacteria 6.56 ± 1.19a 7.85 ± 0.96b 7.63 ± 0.99b 6.39 ± 2.08a 7.82 ± 1.63a 7.75 ± 1.23a
Actinobacteria 7.87 ± 3.04a 8.57 ± 2.49a 8.69 ± 2.18a 8.76 ± 2.77a 9.53 ± 2.24a 9.67 ± 1.97a
Bifidobacterium 6.37 ± 1.54a,* 10.03 ± 0.77b 9.73 ± 2.07b 8.54 ± 1.95a 10.65 ± 2.08b 10.33 ± 1.74b
Eggerthella lenta 8.00 ± 0.38a,* 9.92 ± 0.95b 9.74 ± 0.84b 9.05 ± 0.86a 10.02 ± 1.03b 9.94 ± 0.84b
Bacteroidetes 8.95 ± 0.5a 9.78 ± 0.65b 9.85 ± 0.89b 8.98 ± 0.63a 10.18 ± 0.49b 10.33 ± 0.54b
Bacteroides 9.28 ± 0.81a,* 7.64 ± 2.59b 7.47 ± 1.25b 8.34 ± 0.92a 7.58 ± 2.14a 7.48 ± 1.68a
Bacteroides uniformis 9.71 ± 0.69a 8.74 ± 1.41a 9.46 ± 0.94a 10.25 ± 0.95a 8.30 ± 1.00b 9.19 ± 1.17b
Parabacteroides distasonis 9.26 ± 0.73a,* 9.62 ± 0.40a 10.09 ± 1.12a 7.20 ± 2.40a 8.92 ± 1.40a 9.32 ± 1.98a
Prevotella 6.92 ± 0.69a,* 8.74 ± 0.77b 8.93 ± 0.99b 8.93 ± 0.72a 9.40 ± 0.81a 9.36 ± 0.78a
Firmicutes 9.92 ± 0.35a,* 8.42 ± 0.63b 8.31 ± 0.75b 8.38 ± 0.52a 8.09 ± 0.91a 7.97 ± 0.42a
Blautia coccoides–Eubacterium rectale group 4. 09 ± 0.60a,* 6.69 ± 0.89b 6.79 ± 0.62b 6.82 ± 0.68a 7.27 ± 0.65a 6.99 ± 0.34a
Enterococcus 5.71 ± 1.42a 5.90 ± 0.76a 5.74 ± 1.08a 4.66 ± 0.81a 4.71 ± 1.15a 4.75 ± 1.38a
Clostridium 5.43 ± 1.69a,* 3.13 ± 0.90b 3.09 ± 0.92b 3.97 ± 1.42a 3.56 ± 1.52a 3.47 ± 1.03a
Clostridium histolyticum group 4.08 ± 1.07a,* 2.88 ± 0.55b 3.10 ± 0.50b 3.16 ± 0.92a 2.50 ± 0.96a 2.59 ± 0.77a
Lactobacillus 4.30 ± 1.61a,* 6.83 ± 0.56b 6.63 ± 0.87b 5.78 ± 1.43a 6.34 ± 1.14a 6.46 ± 1.21a
Faecalibacterium prausnitzii 6.90 ± 0.96a,* 9.45 ± 1.12b 9.32 ± 1.09b 8.23 ± 1.21a 9.57 ± 1.32b 9.49 ± 0.98b
Roseburia 8.42 ± 1.12a,* 10.85 ± 1.43b 10.78 ± 1.34b 9.80 ± 1.17a 11.21 ± 1.37b 11.07 ± 1.10b
Values are presented as means ± SD and expressed as log10 copies per gram of feces. N = 10 participants per group. Values in a row with diﬀerent
superscript letters are significantly diﬀerent P < 0.05. *Diﬀerences between MetS patients and healthy subjects at baseline P < 0.05. §Diﬀerences
between MetS patients and healthy subjects after red wine intake P < 0.05. ¥Diﬀerences between MetS patients and healthy subjects after de-
alcoholized red wine intake P < 0.05.
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β = 0.342, R2 = 0.750) and the decrease in the number of
Enterobacter cloacae (P = 0.032, β = −0.564, R2 = 0.98). In the
healthy group, after a multivariate regression analysis, only the
decrease in Clostridium was associated with the decrease in
SBP (P = 0.001, β = −1.019, R2 = 0.99).
Discussion
In the current study we have shown that the diﬀerences in the
composition of fecal microbiota found between the MetS
patients and the healthy subjects disappeared after a regular
intake of red wine and de-alcoholized red wine polyphenols
during one month. Specifically, there was a significant
increase in the abundance of intestinal barrier protectors and
butyrate-producing bacteria and a significant decrease in LPS
producers in the MetS group after polyphenol interventions
(red wine and de-alcoholized red wine). In order to analyze the
fecal microbiota characteristics under MetS conditions, as well
as to observe the eﬀect of red wine polyphenols on this micro-
biota, we had to exclude the influence of confounding factors
such as age, gender, diet and race from this study.
PCR-DGGE was used to analyze the predominant fecal bac-
terial populations in order to compare the bacterial diversity
and similarity between the two study groups after the red wine
and de-alcoholized red wine intake periods. The results
revealed that the diversity and similarity of the dominant bac-
terial composition in the MetS patients were not significantly
diﬀerent from those of the healthy subjects after the two red
wine interventions.
Sequence analysis of all DGGE bands obtained allowed the
association of specific bacterial genotypes with the MetS or a
healthy status. Previous studies have shown the dominance of
Bacteroidetes, Firmicutes and Proteobacterias in the feces of
both groups of subjects. The main diﬀerences found were at
the genus-division of bacteria within these phyla at baseline
between the MetS patients and the healthy subjects. We
found that within Bacteroidetes, the Prevotella genus was
associated with healthy subjects, while the Bacteroides genus
was prevalent in the MetS group. Given the concept of “entero-
types”, i.e., the assignment of an individual microbiome to
a given enterotype based upon the relative enrichment of that
microbiome in one of the three genera: Bacteroides (entero-
type 1), Prevotella (enterotype 2) or Ruminococcus (enterotype
3),41 the MetS gut microbiomes could be classified into enter-
otype 1 and the healthy microbiomes could be classified into
enterotype 2. In addition, the apparent baseline association
between the Escherichia genus and the MetS group, as well as
the lack of Bifidobacterium and Lactobacillus genera in the
same group, is noteworthy. However, after the intake of red
wine and de-alcoholized red wine, the dominant microbiota
genera were not significantly diﬀerent in the MetS patients
compared to healthy subjects, demonstrating the prebiotic
capacity of the red wine polyphenols, able to change the
dominant microbiota community associated with the MetS
conditions.
Table 7 Correlations between gut microbiota composition and blood pressure, glucose level, plasma lipid proﬁle and inﬂammation markers in
MetS patients
Triglycerides Cholesterol HDL-cholesterol LPS CRP Glucose
Actinobacterias −0.989 (0.001)
Clostridium 0.882 (0.048) 0.882 (0.048)
Escherichia coli 0.972 (0.006) 0.942 (0.005) 0.915 (0.029)
Lactobacillus −0.915 (0.030) −0.992 (0.007)
Bacteroidetes −0.916 (0.029)
Bacteroides uniformis −0.956 (0.011)
Bifidobacterium −0.908 (0.033) 0.917 (0.028) −0.906 (0.034)
Eggerthella lenta 0.901 (0.037)
Enterobacter cloacae 0.971 (0.029)
Faecalibacterium prausnitzii −0.997 (0.001)
Roseburia −0.937 (0.030)
Correlations are reported by Spearman’s Rho (r) and P-values are given in parentheses. Statistical significance was set at a P value of <0.05.
Table 8 Correlations between gut microbiota composition and blood pressure, glucose level and plasma lipid proﬁle in healthy subjects
HDL-cholesterol SBP Glucose
Proteobacteria −0.945 (0.015) 0.912 (0.031)
Blautia coccoides–Eubacterium rectale group 0.946 (0.015)
Clostridium −0.904 (0.035) 0.982 (0.003)
Lactobacillus −0.908 (0.003)
Faecalibacterium prausnitzii −0.907 (0.032)
Correlations are reported by Spearman’s Rho (r) and P-values are given in parentheses. Statistical significance was set at a P value of <0.05.
Food & Function Paper
This journal is © The Royal Society of Chemistry 2015 Food Funct.
Pu
bl
ish
ed
 o
n 
13
 N
ov
em
be
r 2
01
5.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
t d
e B
ar
ce
lo
na
 o
n 
28
/0
1/
20
16
 1
3:
35
:4
0.
 
View Article Online
As DGGE is considered a semi-quantitative tool for monitor-
ing the dynamics of the predominant bacterial species of fecal
microbiota, an additional analysis with real-time quantitative
PCR was performed to obtain a quantitative estimation of the
changes found in the gut microbiota between the MetS
patients and healthy subjects at baseline and after the red
wine and de-alcoholized red wine intake periods. We found
that at baseline the MetS patients had a significantly lower
number of Bifidobacterium, Eggerthella lenta, Prevotella, Blautia
coccoides–Eubacterium rectale group, Lactobacillus, Faecali-
bacterium prausnitzii and Roseburia and significantly more Proteo-
bacteria, Firmicutes, Escherichia coli, Enterobacter cloacae,
Bacteroides, Parabacteroides distasonis, Clostridium spp. and
Clostridium histolitycum in their gut microbiota compared
to healthy subjects. After the polyphenol interventions
(red wine and de-alcoholized red wine), however, we found no
significant diﬀerences in the microbiota between the two
study groups.
After the red wine and de-alcoholized red wine intake
periods, in the MetS patients we observed a significant
decrease in Bacteroides and a significant increase in protectors
of the gut mucosal barrier, such as Bifidobacterium spp. and
Lactobacillus spp., possibly due to their capacity to degrade
phenolic compounds such as anthocyanin metabolites.42
Other studies by Vendrame et al.43 and Hidalgo et al.44 also
indicated that anthocyanins seemed to increase the number of
Bifidobacterium spp. and Lactobacillus spp. in the human gut
microbiota of healthy subjects. Moreover, previous studies
have also suggested that dietary polyphenols may help to
improve the growth of certain Lactobacillus strains, which may
mitigate the inflammation by promoting the normalization of
intestinal microflora and exclusion of pathogens, decreasing
intestinal permeability, improving the intestine’s immunologi-
cal barrier functions and alleviating the intestinal inflamma-
tory response.45
In addition, Hidalgo et al.44 investigated the eﬀect of gallic
acid, which is a structural component of ellagitannins, on
human gut microflora, showing a clear inhibition of the
growth of potentially harmful gut bacteria of the Clostridium
histolyticum group, which includes important pathogens
closely related to the progression of colon cancer and the
onset of inflammatory bowel disease. Another intervention
study with cocoa flavan-3-ols in healthy volunteers has shown
that they enhance the growth of Lactobacillus spp. and Bifido-
bacterium spp. and limit the growth of the Clostridium histo-
lyticum group.46 Similar results have been reported by us on
the number of Clostridium histolyticum groups after red wine
and de-alcoholized red wine intake periods in MetS patients,
suggesting that red wine polyphenols have an inhibitory eﬀect
on the growth of these bacteria. Diﬀerences in the cell surface
structures could explain why Gram-positive clostridial type bac-
teria are more sensitive to the bactericidal eﬀects of these com-
pounds that are Gram-negative species.47
At baseline, the MetS patients weighed significantly more
than their healthy controls and after red wine and de-alcoho-
lized red wine consumption, the MetS patients showed a
greater reduction in body weight than healthy controls,
although this reduction was not statistically significant. The
weight decrease observed in this study is probably related to
the alteration in the balance between the Bacteroidetes and Fir-
micutes groups in favor of Bacteroidetes, in part possibly due to
the polyphenol content of the wine. This prevalence of Bacter-
oidetes found following regular wine ingestion (red wine and
de-alcoholized red wine) could be due to Firmicutes possessing
a disproportionately smaller number of glycan-degrading
enzymes than Bacteroidetes, this being the possible mechan-
ism by which polyphenols may exert their eﬀect on lowering
weight.48 Moreover, our results clearly showed that red wine
and de-alcoholized red wine significantly decreased SBP and
DBP in the MetS patients and these results agree with those of
other studies, which have reported that polyphenols reduce
elevated blood pressure.49
Interestingly, polyphenols and polyphenols plus ethanol
significantly reduced the blood glucose levels in the MetS
patients compared to baseline, possibly due to the shift in the
gut microbiota to a higher proportion of Gram-positive relative
to Gram-negative bacteria produced by the presence of poly-
phenols. It has been found that type 2 diabetes mellitus might
be associated with the dominance of Gram-negative bacteria in
the gut.50 This study has shown that polyphenol and poly-
phenol plus ethanol intake positively aﬀected the growth of the
Blautia coccoides–Eubacterium rectale group, Faecalibacterium
prausnitzii and Roseburia the most abundant intestinal buty-
rate producing bacteria. Previous studies have shown that buty-
rate induces mucin synthesis,51 decreases bacterial transport
across the epithelium,52 and improves gut integrity by increas-
ing the tight junction assembly.53 Moreover, we have found
that the increase in the abundance of Faecalibacterium praus-
nitzii was associated with the decrease in blood glucose levels
in MetS patients. This association may be related to the role of
the short-chain fatty acids such as butyrate formed by this gut
microbiota in the regulation of the levels of gut hormones
such as glucose-dependent insulinotropic polypeptide and glu-
cagon-like peptide 1, which have important eﬀects on carbo-
hydrate metabolism.54
In addition to this regulation in insulin sensitivity, we
found that the regular intake of red wine, with or without
ethanol, generated significant decreases in the plasma levels
of triglycerides and total cholesterol and an increase in plasma
levels of HDL-cholesterol in the MetS patients during the
study. In this study, the decrease observed in the plasma chole-
sterol concentration could be related to the significant increase
in Bifidobacterium induced by red wine polyphenols, a bacterial
genus that has the capacity to produce beneficial organic acids
(lactate and acetate) and the ability to inhibit the growth of
pathogenic bacteria,55 and that has been previously associated
with the reduction of plasma cholesterol levels.56,57 Moreover,
we observed a negative association between the number of
Bifidobacterium and the plasma cholesterol levels in the MetS
patients in our study. Additionally, gut microbiota can increase
energy metabolism and have a systemic eﬀect on host lipid
metabolism, especially increasing triglyceride clearance.58
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On the other hand, the significant increase in the numbers of
Eggerthella lenta (bacteria able to degrade resveratrol into
dihydroresveratrol) found in both study groups was related to
the significant enhancement of dihydroresveratrol found after
de-alcoholized red wine and red wine intake with respect to
baseline. Claus et al. showed an association between the genus
Eggerthella and host metabolism and especially hepatic trigly-
ceride levels in mice.59
Low grade inflammatory signaling has been suggested to be
one of the mechanisms linking gut microbiota to the MetS.60
In our study we observed that LPS plasma concentrations were
significantly increased two-fold in the MetS patients with
respect to healthy subjects at baseline. This plasma endotoxin
increase may derive from enhanced LPS production by gut
microbiota (metabolic endotoxemia) or from increased intesti-
nal LPS absorption.61 But after the red wine and de-alcoho-
lized red wine intake periods the plasma endotoxin load (LPS)
was significantly reduced, accompanied by a concomitant
decrease in CRP (a well-defined biomarker for low-grade
inflammation), resulting in an important alleviation of the
inflammatory condition. This situation may be explained by
the observed decrease in the number of lipopolysaccharide
producers (Escherichia coli and Enterobacter cloacae)62 and the
increase in intestinal barrier protectors such as Bifidobacterium
spp. after the polyphenol and polyphenol plus ethanol intake
periods in the MetS patients compared to the baseline level.
Moreover, we found a significant negative and a significant
positive association between Bifidobacterium spp. and Entero-
bacter cloacae, respectively, and the plasma level of LPS in the
MetS patients. Similarly, Cani et al.,60 using animal models,
observed an inverse correlation between the number of Bifido-
bacterium and the LPS levels after a high-fat diet. These data
show that changes in the gut microbiota produced by red wine
and de-alcoholized red wine may cause a decrease in the
release of LPS in the bloodstream of the host due to an
enhancement of the intestinal barrier integrity produced by
changes in the gut microbiota, improving insulin sensitivity
and obesity in the MetS patients.
These study findings indicate that polyphenols or small
ethanol doses plus polyphenol intake for a short time can
generate an important change in the gut microbiota, which
may influence the host metabolism. Moreover, we also
observed that small ethanol doses did not block the poly-
phenols from doing their protective work.
Conclusion
A moderate intake of red wine by obese adults with the MetS
resulted in positive eﬀects on the composition of the gut
microbiota and a reduction in the metabolic syndrome risk
markers. Due to the dominating role of diet in shaping the
composition of the gut microbiota, modulation of the gut
microbiota by nutrients with prebiotic properties such as red
wine could be an eﬀective strategy for managing metabolic dis-
eases associated with obesity.
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